Epidermal growth factor receptor activity mediates renal cyst formation in polycystic kidney disease

Journal of Clinical Investigation

Volumn 101, Issue 5, 1998, Pages 935-939

  Richards, William G ^a,d   Sweeney, William E ^b   Yoder, Bradley K ^a,e   Wilkinson, J Erby ^c   Woychik, Richard P ^a,b   Avner, Ellis D ^b  

^a OAK RIDGE NATIONAL LABORATORY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c UNIVERSITY OF TENNESSEE   (United States)

^d AMGEN INC   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Epidermal growth factor receptor; Mouse mutations; Polycystic kidney disease; Tyrosine kinase activity

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE MUTATION; KIDNEY CYST; KIDNEY POLYCYSTIC DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0032030918     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI2071     Document Type: Article

References (31)

1. Guay-Woodford, L.M., G. Muecher, S.D. Hopkins, E.D. Avner, G.G. Germino, A.P. Guillot, J. Herrin, R. Holleman. D.A. Irons. W. Primack, et al. 1995. The severe perinatal form of autosomal recessive polycystic kidney disease maps to chromosome 6p21.1-p12: implications for genetic counseling. Am. J. Hum. Genet. 56:1101-1107.
2. Zerres, K., G. Muchcr, L. Bachner, G. Deschennes, T. Eggermann, H. Kaariainen, M. Knapp, T. Lennert, J. Misselwitz. K.E. von Muhlendahl, et al. 1994. Mapping of the gene for autosomal recessive polycystic kidney disease (ARPKD) to chromosome 6p21-cen. Nat. Genet. 7:429-432.
3. McDonald, R., and E.D. Avner. 1995. Murine models of polycystic kidney disease. In Polycystic Kidney Disease. M. Watson and V.E. Torres, editors. Oxford University Press, New York. 63-87.
4. Grantham, J.J. 1993. Polycystic kidney disease: hereditary and acquired Adv, Intern. Med. 38:409-420.
5. Grantham, J.J. 1994. Pathogenesis of renal cyst expansion: opportunities for therapy. Am. J. Kidney Dis. 23:210-218.
6. Orellana, S., and E.D. Avner. 1995. Cystic maldevelopment of the kidney. Semin. Nephrol. 15:341-352.
7. Horikoshi, S., S. Kubota, G.R. Martin, Y. Yamada, and P.E. Klotman. , 1991. Epidermal growth factor (EGF) expression in the congenital polycystic mouse kidney. Kidney Int. 39:57-62.
8. Gattone, V.H., G.K. Andrews, F.W. Niu, L.J. Chadwick, R.M. Klein, and J.P. Calvet. 1990. Defective epidermal growth factor gene expression in mice with polycystic kidney disease. Dev. Biol. 138:225-230.
9. Avner, E.D. 1995. Role of growth factors in cell proliferation. Kidney Int. 47:719-720.
10. Avner, E.D., and W.E. Sweeney. 1995. Apical epidermal growth factor receptor expression defines a distinct cystic tubular epithelial phenotype in autosomal recessive polycystic kidney disease. Pediatric Res. 37:359A.
11. Wilson, P.D., J. Du, and J.T. Norman. 1993. Autocrine, endocrine and paracrine regulation of growth abnormalities in autosomal dominant polycystic kidney disease. Eur. J. Cell Biol. 61:131-138.
12. Du, J., and P.D. Wilson. 1995. Abnormal polarization of EGF receptors and autocrine stimulation of cyst epithelial growth in human ADPKD. Am. J. Physiol. 269:C487-C495.
13. Orellana, S.A., W.E. Sweeney, C.D. Neff, and E.D. Avner. 1995. Epidermal growth factor receptor expression is abnormal in murine polycystic kidney. Kidney Int. 47:490-499.
14. Mover, J.H., M.J. Lee-Tischler, H.Y. Kwon, J.J. Schrick, E.D. Avner. W.E. Sweeney, V.L. Godfrey, N.L. Cacheiro, J.E. Wilkinson, and R.P. Woychik. 1994. Candidate gene associated with a mutation causing recessive polycystic kidney disease in mice. Science. 264:1329-1333.
15. Luetteke, N.C., H.K. Phillips, T.H. Qiu, N.G. Copeland, H.S. Earp, N.A. Jenkins, and D.C. Lee. 1994. The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase. Genes Dev. 8:399-413.
16. Laitinen, L., I. Virtanen, and L. Saxon. 1987. Changes in glycosylation pattern during embryonic development of the mouse kidney as revealed with lectin conjugates. J. Histochem. Cytochem. 35:55-65.
17. Avner, E.D., and W.E. Sweeney. 1990. Polypeptide growth factors in metanephric growth and segmental nephron differentiation. Pediatr. Nephrol. 4:372-377.
18. Avner, E.D., W.E. Sweeney, Jr., D.N. Finegold, N.P. Piesco, and D. Ellis. 1985. Sodium-potassium ATPase activity mediates cyst formation in metanephric organ culture. Kidney Int. 28:447-455.
19. Pugh, J.L., W.E. Sweeney, Jr., and E.D. Avner. 1995. Tyrosine kinase activity of the EGF receptor in murine metanephric organ culture. Kidney Int. 47:774-781.
20. Fowler, K.J., F. Walker, W. Alexander, M.L. Hibbs, E.C. Nice. R.M. Bohmer, G.B. Mann, C. Thumwood, R. Maglitto. I.A. Danks. et al. 1995. A mutation in the epidermal growth factor receptor in waved-2 mice has a profound effect on receptor biochemistry that results in impaired lactation. Proc. Natl. Acad. Sci. 92:1465-1469.
21. Yoder, B.K., W.G. Richards, W.E. Sweeney, J.E. Wilkinson. E.D. Avner, and R.P. Woychik. 1995. Insertional mutagenesis and molecular analysis of a new gene associated with polycystic kidney disease. Proc. Assoc. Am. Physicians. 107:314-323.
22. Avner, E.D., W.E. Sweeney, J.E. Wilkinson, and R.P. Woychik. 1993. Abnormal epidermal growth factor receptor (EGF-R) expression in congenital murine polycystic kidney disease (PKD) created through insertional mutagenesis. J. Am. Soc. Nephrol. 4:810.
23. Yoder, B.K., W.G. Richards, C. Sommardahl. W.E. Sweeney, E.J. Michaud. J.E. Wilkinson, E.D. Avner, and R.P. Woychik. 1996. Functional correction of renal defects in a mouse model for ARPKD through expression of the cloned wild-type 7g737 cDNA. Kidney Int. 50:1240-1248.
24. Threadgill, D.W., A.A. Dlugosz, L.A. Hansen, T. Tennenbaum, U. Lichti, D. Yee, C. LaMantia, T. Mourton, K. Herrup, R.C. Harris, et al. 1995. Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science. 269:230-234.
25. Sibilia, M., and E.F. Wagner. 1995. Strain-dependent epithelial defects in mice lacking the EGF receptor. Science. 269:234-238.
26. Gardner, K.D., R.H. Glew, A.P. Evan, J.A. McAteer, and J. Bernstein. 1994. Why renal cysts grow. Am. J. Physiol. 266:F353-F359.
27. Avner, E.D., W.E. Sweeney, and R.P. Woychik. 1995. Inhibition of epidermal growth factor receptor activity modulates collecting tubule cystogenesis in vitro. J. Am. Soc. Nephrol. 6:690.
28. Gattone, V.H., D.A. Lowden, and B.D. Cowley. 1995. Epidermal growth factor ameliorates autosomal recessive polycystic kidney disease in mice. Dev. Biol. 169:504-510.
29. Hammerman, M.R., and S.B. Miller. 1994. Therapeutic use of growth factors in renal failure. J. Am. Soc. Nephrol. 5:1-11.
30. Lowden, D.A., G.W. Lindemann, G. Merlino, B.D. Barash, J.P. Calvet. and V.H. Gattone. 1994. Renal cysts in transgenic mice expressing transforming growth factor-alpha. J. Lab. Clin. Med. 124:386-394.
31. Yaish, P., C. Gilon, and A. Levitzki. 1988. Blocking of EGF-dependent cell proliferation by EGF receptor kinase inhibitors. Science. 242:933-935.